Multicenter, randomized, 2-arm parallel-group, double blind, placebo-controlled study in patients suffering from Otomycosis. This study will compare the efficacy and safety of SVT-15652 otic solution to that of Placebo, when administering one vial twice daily during 14 days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
217
Carolina Ear,Nose and Throat Clinic
Orangeburg, South Carolina, United States
Therapeutical Cure (Clinical and Mycological Cure)
Number and percentage of subjects with therapeutic cure
Time frame: Test of cure on day 24
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.